PCA
KURA icon

Pallas Capital Advisors’s Kura Oncology KURA Stock Holding History

Pallas Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174K Sell
21,414
-8,775
-29% -$75.4K 0.01% 779
2025
Q4 		$314K Buy
30,189
+6,112
+25% +$64.1K 0.01% 666
2025
Q3 		$213K Buy
24,077
+10,773
+81% +$76.8K 0.01% 767
2025
Q2 		$76.8K Buy
13,304
+3,241
+32% +$19.9K ﹤0.01% 808
2025
Q1 		$66.4K Buy
+10,063
New +$78.4K ﹤0.01% 720

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pallas Capital Advisors's KURA Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Kura Oncology (KURA) stake by 29% in Q1 2026, selling an estimated $75.4K and leaving 21,414 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #779.

Pallas Capital Advisors first reported a position in KURA in Q1 2025 and has held it in 5 quarters since. The position peaked at $314K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Pallas Capital Advisors held 21,414 shares of Kura Oncology worth $174K as of Q1 2026.
  • Pallas Capital Advisors sold 8,775 Kura Oncology shares in Q1 2026, an estimated $75.4K.
  • Kura Oncology made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #779 holding.
  • Pallas Capital Advisors first reported a position in Kura Oncology in Q1 2025 and has held it in 5 quarters since.
  • Pallas Capital Advisors's Kura Oncology position peaked at $314K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.